Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Transient receptor potential vanilloid 2 channel (TRPV2)** is a member of the TRP superfamily of cation channels, widely recognized as a non-selective, calcium-permeable ion channel within the vanilloid subfamily[1][3]. While homologous to TRPV1, TRPV2 has distinct activation properties and is insensitive to classic TRPV1 agonists like capsaicin and heat[1][4]. TRPV2 plays roles in signal transduction associated with mechanosensation, nociception, and osmotic regulation, and is expressed in a range of tissues including sensory neurons, immune cells, and the heart[5][6]. Structurally, TRPV2 forms a tetrameric channel with conserved pore domains and ankyrin repeat domains facilitating protein-protein interactions and gating regulation[6]. TRPV2 has been implicated in cancer, inflammation, and neurological and cardiovascular disorders, making it an emerging therapeutic target with modulators such as cannabidiol and 2-APB being active at the channel[7][8][3]. Safety considerations for drugs targeting TRPV2 include potential disruptions to cellular calcium handling and off-target effects due to homology with other TRPV family members.
Agonists and modulators can activate or inhibit channel opening, altering cation flow (primarily Ca²⁺ and Na²⁺), leading to changes in cell signaling and excitability
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential vanilloid 2 channel (TRPV2).